• Andrew, M., Mitchell, L., Vegh, P. & Ofosu, F. (1994a) Thrombin regulation in children differs from adults in the absence and presence of heparin. Thrombosis and Haemostasis, 72, 836842.
  • Andrew, M., Marzinotto, V., Massicotte, P., Blanchette, V., Ginsberg, J., Brill-Edwards, P., Burrows, P., Benson, L., Williams, W., David, M., Poon, A. & Sparling, K. (1994b) Heparin therapy in pediatric patients: a prospective cohort study. Pediatric Research, 35, 7883.
  • Basu, D., Gallus, A., Hirsh, J. & Cade, J. (1972) A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. The New England Journal of Medicine, 287, 324327.
  • Chan, A., Black, L., Ing, C., Brandao, L. & Williams, S. (2007) Utility of aPTT in monitoring unfractionated heparin in children. Thrombosis Research, 122, 135136.
  • Doan, J., Newall, F., Ignjatovic, V. & Monagle, P. (2009) Compliance of indicated antithrombotic management at the Royal Children’s Hospital with international guidelines: a 75-day audit. Journal of Thrombosis and Haemostasis, 7, 1080S (Abstract).
  • Hirsh, J. (1991) Heparin. The New England Journal of Medicine, 324, 15651574.
  • Hirsh, J. & Raschke, R. (2004) Heparin and low-molecular-weight heparin. Chest, 126, 188S203S.
  • Hirsh, J., Bauer, K., Donati, M., Gould, M., Samama, M. & Weitz, J. (2008) Parenteral anticoagulants. Chest, 133, S141S159.
  • Hull, R., Raskob, G., Rosenbloom, D., Panju, A., Brill-Edwards, P. & Ginsberg, J. (1990) Heparin for 5 days as compared to 10 days in the initial treatment of proximal venous thrombosis. New England Journal of Medicine, 322, 12601264.
  • Ignjatovic, V., Furmedge, J., Newall, F., Chan, A., Berry, L., Fong, C., Cheng, K. & Monagle, P. (2006a) Age-related differences in heparin response. Thrombosis Research, 118, 741745.
  • Ignjatovic, V., Summerhayes, R., Than, J., Gan, A. & Monagle, P. (2006b) Therapeutic range for unfractionated heparin therapy: age-related differences in response in children. Journal of Thrombosis and Haemostasis, 4, 22802282.
  • Kitchen, S. & Preston, F. (1996) The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays. Thrombosis and Haemostasis, 75, 734739.
  • Kitchen, S., Theaker, J. & Preston, F. (2000) Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay. Blood, Coagulation and Fibrinolysis, 11, 137144.
  • Kuhle, S., Eulmesekian, P., Kavanagh, B., Massicotte, P., Vegh, P., Lau, A. & Mitchell, L. (2007a) Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children. Haematologica, 92, 554557.
  • Kuhle, S., Eulmesekian, P., Kavanagh, B., Massicotte, P., Vegh, P. & Mitchell, L. (2007b) A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study. Haematologica, 92, 244247.
  • Lin, R.-G. & Watanabe, T. (2007) Hospital drug errors far from uncommon. Los Angeles Times, 22 November 2007.
  • Monagle, P., Chalmers, E., Chan, A., DeVeber, G., Kirkham, F., Massicotte, P. & Michelson, A. (2008) Antithrombotic therapy in neonates and children: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest, 133, 887S968S.
  • Newall, F., Barnes, C., Ignjatovic, V. & Monagle, P. (2003) Heparin-induced thrombocytopaenia in children. Journal of Paediatrics and Child Health, 39, 289292.
  • Newall, F., Ignjatovic, V., Johnston, L. & Monagle, P. (2009a) Unfractionated heparin therapy in infants and children. Pediatrics, 123, e510e518.
  • Newall, F., Ignjatovic, V., Summerhayes, R., Gan, A., Butt, W., Johnston, L. & Monagle, P. (2009b) In vivo age dependency of unfractionated heparin in infants and children. Thrombosis Research, 123, 710714.
  • Newall, F., Johnston, J., Ignjatovic, V., Summerhayes, R. & Monagle, P. (2009) Refinement and feasibility testing of a manual micro-method for protamine titration. International Journal of Laboratory Hematology, 31, 457461.
  • Newall, F., Ignjatovic, V., Johnston, L., Summerhayes, R., Lane, G., Cranswick, N. & Monagle, P. (2010) Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin. Thrombosis and Haemostasis, 103, 10851090.
  • Refn, I. & Vestergaard, L. (1954) The titration of heparin with protamine. Scandinavian Journal of Clinical and Laboratory Investigation, 6, 284287.
  • Schmidt, B., Mitchell, L., Ofosu, F. & Andrew, M. (1988) Standard assays underestimate the concentration of heparin in neonatal plasma. Journal of Laboratory and Clinical Medicine, 112, 641643.